Kwong D L, Sham J S, Chua D T, Choy D T, Au G K, Wu P M
Department of Radiation Oncology, University of Hong Kong, Queen Mary Hospital, Hong Kong.
Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):703-10. doi: 10.1016/s0360-3016(97)00339-8.
The effect of interruptions and prolonged overall treatment time in radiotherapy for nasopharyngeal carcinoma and the significance of timing of interruption was investigated.
Treatment records of 229 patients treated with continuous course (CC) and 567 patients treated with split course (SC) radiotherapy for nonmetastatic NPC were reviewed. Overall treatment time without inclusion of time for boost was calculated. Treatment that extended 1 week beyond scheduled time was considered prolonged. Outcome in patients who completed treatment "per schedule" were compared with those who had "prolonged" treatment. Because of known patient selection bias between CC and SC, patients on the two schedules were analyzed separately. Multivariate analysis was performed for patients on SC. Total number of days of interruption, age, sex, T and N stage, and the use of boost were tested for the whole SC group. Analysis on the effect of timing of interruption was performed in a subgroup of 223 patients on SC who had a single unplanned interruption. Timing of interruption, either before or after the fourth week for the unplanned interruption, was tested in addition to the other variables in multivariate analysis for this subgroup of SC.
Twenty-seven (11.8%) patients on CC and 96 (16.9%) patients on SC had prolonged treatment. Patients on SC who had prolonged treatment had significantly poorer loco-regional control rate and disease free survival when compared with those who completed radiotherapy per schedule (p = 0.0063 and 0.001, respectively, with adjustment for stage). For CC, the effect of prolonged treatment on outcome was not significant. The small number of events for patients on CC probably account for the insignificant finding. The number of days of interruption was confirmed as prognostic factor, independent of T and N stages, for loco-regional control and disease-free survival in multivariate analysis for SC. The hazard rate for loco-regional failure increased by 3.3% for each day of interruption. The timing of interruption, at the beginning or towards end of treatment, did not significantly alter outcome.
Interruptions and prolonged treatment adversely affect outcome in radiotherapy for NPC and the effect of repopulation was confirmed. Every effort should be made to keep treatment on schedule and interruptions for whatever reasons should be minimized.
探讨鼻咽癌放疗过程中的中断及总治疗时间延长的影响以及中断时机的意义。
回顾了229例接受连续疗程(CC)放疗和567例接受分割疗程(SC)放疗的非转移性鼻咽癌患者的治疗记录。计算了不包括追加剂量时间的总治疗时间。超过预定时间1周以上的治疗被视为延长治疗。将“按计划”完成治疗的患者与“延长”治疗的患者的结局进行比较。由于CC和SC之间存在已知的患者选择偏倚,对两种治疗方案的患者分别进行分析。对SC方案的患者进行多因素分析。对整个SC组检验中断天数、年龄、性别、T和N分期以及追加剂量的使用情况。在223例接受SC方案且有单次计划外中断的患者亚组中分析中断时机的影响。除了该SC亚组多因素分析中的其他变量外,还检验了计划外中断在第四周之前或之后的中断时机。
CC方案中有27例(11.8%)患者和SC方案中有96例(16.9%)患者出现治疗延长。与按计划完成放疗的患者相比,SC方案中治疗延长的患者局部区域控制率和无病生存率显著较差(分别调整分期后,p = 0.0063和0.001)。对于CC方案,延长治疗对结局的影响不显著。CC方案患者的事件数量较少可能是导致该无显著发现的原因。在SC方案的多因素分析中,中断天数被确认为局部区域控制和无病生存的预后因素,独立于T和N分期。局部区域失败的风险率每中断一天增加3.3%。中断时机在治疗开始时或接近结束时,并未显著改变结局。
中断和延长治疗对鼻咽癌放疗结局有不利影响,且再增殖的影响得到证实。应尽一切努力按计划进行治疗,无论何种原因导致的中断都应尽量减少。